Champions Oncology Inc
CSBR
Get informed when a big investor buys or sells
+ FollowMarket Cap$68.5M
Close$
$0.09
98.3% downside
Current Fair Value
98.3% downsideOvervalued by 98.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $68.50 Million |
|---|---|
| Enterprise Value | $77.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | 0.41 |
| Outstanding Shares | 13,832,385 |
Return
| Return on Equity | -29.83% |
|---|---|
| Return on Assets | -4.35% |
| Return on Invested Capital | -14.76% |
Valuation & Multiples
| P/E Ratio | -61.63 |
|---|---|
| PEG | 102.28 |
| Price to Sales | 2.64 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.67 |
| Enterprise Value to EBIT | -73.87 |
| Enterprise Value to Net Income | -66 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 3.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 27, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$12.89 M
Average shareholder expectationNext Earnings Call
Expected Date
September 14, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$15.04 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 23,200▼ 35.73% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 41.44%▲ 0.03% |
|---|---|
| Total Invested | $32.96M▼ 17.06% |
| Investors Holding | 25▼ 2.00% |
ESG Score
No data
About Champions Oncology Inc
143 employeesChampions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computa...